The extracorporeal membrane oxygenation market size is projected to reach US$ 0.74 billion by 2031 from US$ 0.58 billion in 2023. The market is expected to register a CAGR of 3.10% during 2023–2031. Surging product developments and approvals will likely remain a key trend in the market.
Extracorporeal Membrane Oxygenation Market Analysis
In 2020, there were 89.1 million cases of ischemic stroke and 68.2 million cases of stroke worldwide. In North America, there are more cases of cardiovascular disease. Globally, heart diseases are becoming more prevalent, with developed nations seeing a sharp rise in their incidence. Changes in lifestyle and other health issues are contributing to an increase in the incidences. The market is expected to grow due to new product releases, technological advancements, and the prevalence of a large population at risk for cardiovascular illnesses. Players like Terumo Group, Medtronic Plc, MicroPort Scientific Corporation, LivaNova Plc, Nioro Medical Corporation, Getinge AB, Braile Biomedica, Fresenius Medical Care AG & Co KGaA, Abiomed Inc., and others make up the majority of the extracorporeal membrane oxygenation (ECMO) market.
Extracorporeal Membrane Oxygenation Market Overview
Respiratory failure may result from airflow obstruction brought on by chronic obstructive pulmonary disease (COPD). It is among the severe illnesses that kill millions of people worldwide. The World Health Organization (WHO) reports that 3.23 million people worldwide died from COPD in 2019, making it the third most common cause of death in 2022. Roughly 90% of deaths from COPD take place in low- and middle-income nations. In 2020, COPD ranked as the sixth most common cause of death in the United States, according to the Centers for Disease Control and Prevention (CDC). Therefore, the market for ECMOs is growing due to the rising prevalence of respiratory failures and cardiovascular diseases.
Customize This Report To Suit Your Requirement
You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities
Extracorporeal Membrane Oxygenation Market: Strategic Insights

- Get Top Key Market Trends of this report.This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities
Extracorporeal Membrane Oxygenation Market: Strategic Insights

- Get Top Key Market Trends of this report.This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
Extracorporeal Membrane Oxygenation Market Drivers and Opportunities
Growing Adoption of ECMO in Lung Transplantation Procedures Favors the Market Growth
For patients with end-stage lung diseases like cystic fibrosis, idiopathic pulmonary fibrosis (IPF), and COPD, lung transplantation is a life-saving treatment option that can enhance quality of life. ECMO is a flexible instrument utilized during the preoperative, intraoperative, and postoperative stages of lung transplantation. It serves as a transitional period for patients receiving lung transplants. As a result, the use of ECMO in lung transplantation is expanding quickly to treat patients whose lung disease poses a serious threat to their lives. The Scientific Registry of Transplant Recipients (SRTR) reports that approximately 4,600 lung transplants are carried out annually worldwide, with North America accounting for 55% of those procedures. The same source states that in the US, 3,243 patients were added to the waiting list, and approximately 2,759 patients received lung transplants. Following a lung transplant, the most common cause of death is primary graft dysfunction (PGD).
Thus, PGD following lung transplantation is treated penultimately with ECMO. The overall incidence of PGD, according to the National Library of Medicine (NLM) in 2022, is 30%. Risk factors for this condition include organ acquisition, preservation methods, intraoperative organ implantation and reperfusion, and preoperative donor lung ischemia. As a result, there is an increasing need for ECMO equipment to treat PGD patients.
Increasing Survival Rates with ECMO Creates Significant Opportunities in the Market
Since ECMO treatments have encouraged survival rates, the use of ECMO for treating respiratory failure has increased recently. In 2021, a study by BioMed Central reported that patients with COVID-19 who experienced respiratory failure and received veno-venous extracorporeal membrane oxygenation (V-V ECMO) had a 60% survival rate. Furthermore, because it improves patient survival rates, ECMO is advised for patients with acute respiratory distress syndrome (ADRS), primary graft dysfunction following lung transplantation, and lung trauma. Additionally, ECMO improves the survival rate of patients whose post-cardiac arrest regimen is impacted. A radical change in the adoption of Westernized lifestyles causes several cardiac conditions. This prompts the major players to make significant R&D investments, which enhances the effectiveness of ECMO treatment and raises the survival rate. As a result, more market opportunities are anticipated during the forecast period due to the increasing survival rate of using ECMO in various treatments.
Extracorporeal Membrane Oxygenation Market Report Segmentation Analysis
Key segments that contributed to the derivation of the extracorporeal membrane oxygenation market analysis are modality, application, and age group.
- Based on modality, the extracorporeal membrane oxygenation market is segmented into venoarterial extracorporeal membrane oxygenation, venovenous extracorporeal membrane oxygenation, and arteriovenous extracorporeal membrane oxygenation. The venoarterial extracorporeal membrane oxygenation segment held the most significant market share in 2023.
- By application, the market is categorized into respiratory and cardiology. The respiratory segment held the largest share of the market in 2023.
- By age group, the market is segmented into adults, pediatrics, and neonates. The adults segment held a significant share of the market in 2023.
Extracorporeal Membrane Oxygenation Market Share Analysis by Geography
The geographic scope of the extracorporeal membrane oxygenation market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.
The North America extracorporeal membrane oxygenation market is segmented into the US, Canada, and Mexico. The presence of essential market players and a growing number of product launches and approvals are vital factors responsible for market growth in the region. Also, the increasing prevalence of cardiovascular diseases and respiratory diseases is likely to favor market growth
Extracorporeal Membrane Oxygenation Market Regional Insights
The regional trends and factors influencing the Extracorporeal Membrane Oxygenation Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Extracorporeal Membrane Oxygenation Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

- Get the Regional Specific Data for Extracorporeal Membrane Oxygenation Market
Extracorporeal Membrane Oxygenation Market Report Scope
Report Attribute | Details |
---|---|
Market size in 2023 | US$ 0.58 Billion |
Market Size by 2031 | US$ 0.74 Billion |
Global CAGR (2023 - 2031) | 3.10% |
Historical Data | 2021-2022 |
Forecast period | 2024-2031 |
Segments Covered |
By Modality
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
Extracorporeal Membrane Oxygenation Market Players Density: Understanding Its Impact on Business Dynamics
The Extracorporeal Membrane Oxygenation Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Extracorporeal Membrane Oxygenation Market are:
- Terumo Group
- Medtronic Plc
- MicroPort Scientific Corporation
- LivaNova Plc
- Nipro Medical Corporation
- Eurosets S.R.L.
Disclaimer: The companies listed above are not ranked in any particular order.

- Get the Extracorporeal Membrane Oxygenation Market top key players overview
Extracorporeal Membrane Oxygenation Market News and Recent Developments
The extracorporeal membrane oxygenation market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the extracorporeal membrane oxygenation market are listed below:
- LivaNova P.L.C., a market-leading medical technology and innovation company, announced it received 510(k) clearance for extracorporeal membrane oxygenation (ECMO) from the US Food and Drug Administration (FDA) for LifeSPARC, the Company’s next-generation Advanced Circulatory Support (ACS) pump and controller system. LivaNova leveraged existing real-world evidence inclusive of data collected during the COVID-19 pandemic to receive this new indication. (Source: LivaNova PLC, Press Release, November 2022)
- Inspira Technologies OXY BHN Ltd. introduces the "Liby™" System, an advanced form of life support better known by the medical industry as extracorporeal membrane oxygenation (ECMO), used to treat patients with life-threatening heart and lung failure. (Source: Inspira Technologies, Press Release, July 2022)
Extracorporeal Membrane Oxygenation Market Report Coverage and Deliverables
The “Extracorporeal Membrane Oxygenation Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:
- Extracorporeal membrane oxygenation market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Extracorporeal membrane oxygenation market trends as well as market dynamics such as drivers, restraints, and key opportunities
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Extracorporeal membrane oxygenation market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments.
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the extracorporeal membrane oxygenation market
- Detailed company profiles
Frequently Asked Questions
What is the expected CAGR of the extracorporeal membrane oxygenation market?
The market is expected to register a CAGR of 3.10% during 2023–2031.
Which are the leading players operating in the extracorporeal membrane oxygenation market?
Terumo Group, Medtronic Plc, Braile Biomedica, LivaNova Plc, Nipro Medical Corporation, MicroPort Scientific Corporation, Eurosets S.R.L., Getinge AB, Fresenius Medical Care AG & Co KGaA
What are the future trends of the extracorporeal membrane oxygenation market?
Surging product developments and approvals will likely remain a key trend in the market.
What are the driving factors impacting the extracorporeal membrane oxygenation market?
Key factors driving the market are the increasing prevalence of cardiovascular diseases and respiratory failures and the growing adoption of ECMO in lung transplantation procedures.
Which region dominated the extracorporeal membrane oxygenation market in 2023?
North America dominated the extracorporeal membrane oxygenation market in 2023
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Testimonials

I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.
DR CHIJIOKE ONYIA, MANAGING DIRECTOR, PineCrest Healthcare Ltd.
The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services
Yukihiko Adachi CEO, Deep Blue, LLC.Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Strategic Planning
- Investment Justification
- Identifying Emerging Markets
- Enhancing Marketing Strategies
- Boosting Operational Efficiency
- Tracking Industry Innovations
- Aligning with Regulatory Trends
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.

















